Buy Score Rank #790 out of #5176
Wed 26'th Jul 2017
Spark Therapeutics Stock Analysis
Technical stock analysis for Wed 26'th Jul 2017
Buy candidate since 2017-07-14 Gain 22.44%
Spark Therapeutics lies in the upper part of a very wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $74.34 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 15.68% during the next 3 months and, with 90% probability hold a price between $65.86 and $86.00 at the end of this period.
Only positive signals in the chart today. Spark Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $68.21 and $61.37. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday July 25, 2017, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
* Golden Star Signal* is when the short-term moving average, the long-term moving average, and priceline meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Relative Strength Index (RSI)
RSI14 is 66 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $69.02 and $64.16. On the upside the stock meets some resistance just above today's level from accumulated volume at $74.01.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Spark Therapeutics finds support just below today's level at $69.02. If this is broken, then the next support from accumulated volume will be at $64.16 and $61.86. The stock is about to test the resistance from accumulated volume at $74.01 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $3.22 between high and low, or 4.57%. For the last week, the stock has had a daily average volatility of 5.85%.
Our recommended stoploss: $69.05 (-4.99%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.
Your capital is at risk.